Alnylam Pharmaceuticals (NASDAQ: ALNY) stock price action has been volatile but is uptrending and has gained 100% in the last ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.89% of ...

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are ...

In this article, we are going to take a look at where Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stands against the other ...

Genomics is on the brink of revolutionizing healthcare with breakthroughs that could redefine treatment and diagnosis. As ...

Alnylam Pharmaceuticals, Inc. (ALNY) stock saw a modest uptick, ending the day at $274.46 which represents a slight increase of $4.09 or 1.51% from the prior close of $270.37. The stock opened at $271 ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Morgan Stanley analyst Michael Ulz maintained a Buy rating on Silence Therapeutics (SLN – Research Report) today and set a price target ...

Financial success starts on the top line. This metric highlights companies expanding sales much faster than their share ...

In terms of liquidity and interest, the mean open interest for Regeneron Pharmaceuticals options trades today is 51.43 with a ...

Broken String Biosciences ("Broken String"), a genomics company enabling development of the next generation of more precise, ...

TD Cowen analyst Ritu Baral maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report) today and set a price target of ...